HSPA5 and hepatocellular carcinoma: The response efficacy to 5-FU is the lowest in QGY-7703 cells, by contrast it is the highest in HepG2 cells, raising the possibility that the expression level of GRP78 may be associated with the sensitivity of HCC cells to 5-FU (Figure 1b).